Michigan senior Carl Hagelin passes the puck around Mercyhurst senior Mike Gurtler in the first period against Mercyhurst at Yost Arena on Saturday night. Melanie Maxwell I AnnArbor.com Any other week, it would have been an ordinary Tuesday afternoon skate. But Tuesday's first full practice of the year finally gave ...
Ann Arbor area scientist Roger Newton's quest to commercialize a drug that raises so-called "good" cholesterol advanced Friday as his startup company, Esperion Therapeutics, launched its first clinical trial.
For most early-stage biotech companies, revenue is but a far-off dream. They rely mostly on investors’ cash or government funding until they’re advanced enough to market a drug or sign licensing deals with major pharmaceutical companies. But the global economic crisis, which has caused investors to scale back on funding ...
Not too many people get the chance to start the same company twice. But Esperion Therapeutics founder Roger Newton is reaping the benefits of learning from his company’s first mistakes and successes. Newton, the Ann Arbor scientist who famously co-discovered Lipitor, the world’s top-selling drug, is cognizant that the second ...
Good nutrition runs in the Newton family. Coco Newton, the wife of Lipitor co-discoverer and Esperion Therapeutics founder Roger Newton, is pursuing her own “functional medicine” practice in the same facility as her husband. Roger Newton’s expertise in cholesterol drugs is well known, but his doctorate degree was in nutrition.Lifetime ...
A life sciences executive who played a key role in the development of local biotech success Esperion Therapeutics is assuming the top job at an Ann Arbor personalized medicine company, officials announced today. Timothy Mayleben, a founding member of Esperion, will become chief executive officer of Aastrom Biosciences when CEO ...